The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

HCP Inc

NYSE: HCP
Last

(U.S.) $45.58

Today's change+0.49 +1.09%
Updated December 22 4:01 PM EST. Delayed by at least 15 minutes.
 

HCP Inc

NYSE: HCP
Last

(U.S.) $45.58

Today's change+0.49 +1.09%
Updated December 22 4:01 PM EST. Delayed by at least 15 minutes.

HCP Inc up (U.S.)$0.49

HCP Inc closed up Monday by (U.S.)$0.49 or 1.09% to (U.S.)$45.58. Over the last five days, shares have gained 1.99% and are currently 1.06% off of the 52-week high. Shares have outperformed the S&P 500 by 12.02% during the last year.

Key company metrics

  • Open(U.S.) $45.16
  • Previous close(U.S.) $45.09
  • High(U.S.) $45.70
  • Low(U.S.) $44.99
  • Bid / Ask-- / --
  • YTD % change+25.50%
  • Volume3,845,903
  • Average volume (10-day)3,203,206
  • Average volume (1-month)2,950,125
  • Average volume (3-month)2,647,709
  • 52-week range(U.S.) $35.95 to (U.S.) $46.07
  • Beta0.60
  • Trailing P/E22.51×
  • P/E 1 year forward22.10×
  • Forward PEG7.37×
  • Indicated annual dividend(U.S.) $2.18
  • Dividend yield4.78%
  • Trailing EPS(U.S.) $2.03
Updated December 22 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+40.39%

Based on its net profit margin of 40.39%, HCP Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.25%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue597536530530
Total other revenue--------
Total revenue597536530530
Gross profit497457454454
Total cost of revenue100797676
Total operating expense248221204202
Selling / general / administrative25292119
Research & development--------
Depreciation / amortization123113107106
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income349315326329
Interest income (expense), net non-operating-111-107-107-110
Gain (loss) on sale of assets--------
Other--------
Income before tax241209221220
Income after tax241208219218
Income tax, total0112
Net income248219259293
Total adjustments to net income00-10
Net income before extra. items248219231234
Minority interest-3-3-3-5
Equity in affiliates10151520
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items247218229233
Inc. avail. to common incl. extra. items247218258293
Diluted net income247218258293
Dilution adjustment--0----
Diluted weighted average shares459459458454
Diluted EPS excluding extraordinary itemsvalue per share0.540.480.500.51
Dividends per sharevalue per share0.550.550.550.53
Diluted normalized EPSvalue per share0.470.490.500.51